LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche Diagnostics Honored with Award

By HospiMedica staff writers
Posted on 22 Nov 2004
Roche Diagnostics (Basel, Switzerland) received the Clinical Diagnostics Company of the Year Award at the Global Excellence in Healthcare & Life Sciences Award Banquet in Naples (FL, USA) in November 2004. The award was presented by Frost & Sullivan, the international market consulting firm (Palo Alto, CA, USA; www.frost.com).

"Roche Diagnostics' dedication to improving people's quality of life globally is certainly visible in its products and services,” commented Manoj Kenkare, vice president, global research, Healthcare & Life Sciences, for Frost & Sullivan. "By keeping its focus on innovation and its commitment to its customers, Roche Diagnostics has maintained its leadership position in clinical diagnostics.”

Frost & Sullivan presents the award each year to a company that has achieved comprehensive excellence. Roche Diagnostics demonstrated excellence in executing marketing strategies, revenues growth, new market penetration, marketing, promotion, and visibility of the company, according to Frost & Sullivan.

"Roche Diagnostics is committed to innovating health information and focusing on our customers,” noted Dick Aderman, senior vice president and general manager, centralized and molecular diagnostics, Roche Diagnostics. "We are honored to receive this award from Frost & Sullivan as a result of our strength in these areas.”




Related Links:
Roche Diagnostics

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
All-in-One Molecular System
AIO M160

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
22 Nov 2004  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
22 Nov 2004  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
22 Nov 2004  |   Industry



PURITAN MEDICAL